Literature DB >> 32565345

Human papillomavirus (HPV) vaccine utilization among adults (18-29 years), BRFSS 2015.

R Constance Wiener1, Patricia A Findley2, Chan Shen3, Nilanjana Dwibedi4, Usha Sambamoorthi5.   

Abstract

Human papillomavirus (HPV) vaccination acceptance is hampered by fears and conflicting attitudes about the need for and safety of vaccine. There are also ethical dilemmas associated with vaccinating adolescents for a sexually transmitted disease despite future cancer risk. The purpose of this research was to determine HPV vaccination acceptance/hesitancy among young adults. Behavioral Risk Factor Surveillance System 2015 data were used. During 2015, 83.1% of adults ages 25-29 years did not receive any HPV vaccination; the UOR was 3.47; 95% CI = 2.11, 5.70) compared to adults 18-24 years. There is a need to accelerate public health messaging/campaigns to increase HPV vaccination rates.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32565345      PMCID: PMC7367495          DOI: 10.1016/j.vaccine.2020.05.056

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

Review 1.  Addressing HPV vaccine myths: practical information for healthcare providers.

Authors:  Robert A Bednarczyk
Journal:  Hum Vaccin Immunother       Date:  2019-02-20       Impact factor: 3.452

2.  Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Elissa Meites; Allison Kempe; Lauri E Markowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-16       Impact factor: 17.586

3.  The HPV vaccine: a content analysis of online news stories.

Authors:  Melissa A Habel; Nicole Liddon; Jo E Stryker
Journal:  J Womens Health (Larchmt)       Date:  2009-03       Impact factor: 2.681

4.  U.S. Primary Care Clinics' Experiences During Introduction of the 9-Valent HPV Vaccine.

Authors:  Melanie L Kornides; William A Calo; Jennifer A Heisler-MacKinnon; Melissa B Gilkey
Journal:  J Community Health       Date:  2018-04

5.  A Survey of Physicians' Attitudes and Practices about the Human Papillomavirus (HPV) Vaccine in Hawai'i.

Authors:  Reni Soon; May Rose I Dela Cruz; JoAnn U Tsark; John J Chen; Kathryn L Braun
Journal:  Hawaii J Med Public Health       Date:  2015-07

6.  Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007.

Authors:  Nidhi Jain; Gary L Euler; Abigail Shefer; Pengjun Lu; David Yankey; Lauri Markowitz
Journal:  Prev Med       Date:  2008-12-06       Impact factor: 4.018

7.  Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.

Authors:  Emiko Petrosky; Joseph A Bocchini; Susan Hariri; Harrell Chesson; C Robinette Curtis; Mona Saraiya; Elizabeth R Unger; Lauri E Markowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-03-27       Impact factor: 17.586

8.  Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58.

Authors:  Silvia de Sanjosé; Beatriz Serrano; Sara Tous; Maria Alejo; Belén Lloveras; Beatriz Quirós; Omar Clavero; August Vidal; Carla Ferrándiz-Pulido; Miquel Ángel Pavón; Dana Holzinger; Gordana Halec; Massimo Tommasino; Wim Quint; Michael Pawlita; Nubia Muñoz; Francesc Xavier Bosch; Laia Alemany
Journal:  JNCI Cancer Spectr       Date:  2019-01-07

9.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.

Authors:  Tanja Y Walker; Laurie D Elam-Evans; David Yankey; Lauri E Markowitz; Charnetta L Williams; Sarah A Mbaeyi; Benjamin Fredua; Shannon Stokley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-24       Impact factor: 17.586

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.